Increase in Net Income for Full Year
Net income for the full year of 2024 increased to $1.02 per diluted share from $0.60 per diluted share in 2023, driven by an increase in net interest income.
Earnings Available for Distribution Growth
Earnings available for distribution increased to $0.83 per diluted common share in Q4 2024 compared to $0.44 in Q4 2023.
Cash Available for Distribution Increase
Cash available for distribution for the full year increased to $2.42 per diluted share in 2024 from $2.05 in 2023, representing an increase of 18%.
Strong Portfolio Performance
The portfolio remains strong with diversified investments and a collateralization rate of 76.5% stabilized assets, a loan-to-value of 59.2%, and a weighted average DSCR of 1.32 times.
Life Sciences and Multifamily Growth Prospects
Life sciences and multifamily sectors are expected to see significant growth with investments in construction financing and advanced manufacturing opportunities.